메뉴 건너뛰기




Volumn 34, Issue 3, 2019, Pages 389-403

Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome

Author keywords

Glucocorticoids; Nephrotic syndrome; Pharmacogenetics; Pharmacology; Prednisolone; Prednisone

Indexed keywords

ABC TRANSPORTER SUBFAMILY B; CELL NUCLEUS RECEPTOR; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; KARYOPHERIN; MIGRATION INHIBITION FACTOR; PREDNISOLONE; PREDNISONE; PREGNANE X RECEPTOR; TUMOR NECROSIS FACTOR; ABCB1 PROTEIN, HUMAN; GLUCOCORTICOID;

EID: 85044041065     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-018-3929-z     Document Type: Article
Times cited : (55)

References (122)
  • 1
    • 80052490816 scopus 로고    scopus 로고
    • Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature
    • PID: 21533870
    • El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA (2011) Nephrotic syndrome in the Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol 26:1241–1246
    • (2011) Pediatr Nephrol , vol.26 , pp. 1241-1246
    • El Bakkali, L.1    Rodrigues Pereira, R.2    Kuik, D.J.3    Ket, J.C.4    van Wijk, J.A.5
  • 2
    • 0030780202 scopus 로고    scopus 로고
    • Prognostic significance of the early course of minimal change nephrotic syndrome: report of the international study of kidney disease in children
    • COI: 1:STN:280:DyaK2szhvF2lsg%3D%3D, PID: 9176846
    • Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the international study of kidney disease in children. J Am Soc Nephrol 8:769–776
    • (1997) J Am Soc Nephrol , vol.8 , pp. 769-776
    • Tarshish, P.1    Tobin, J.N.2    Bernstein, J.3    Edelmann, C.M.4
  • 3
    • 84884315497 scopus 로고    scopus 로고
    • Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis
    • Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274
    • Kidney Int Suppl , vol.2 , pp. 139-274
  • 4
    • 85050588066 scopus 로고    scopus 로고
    • Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers
    • PID: 28592406
    • Samuel SM, Flynn R, Zappitelli M, Dart A, Parekh R, Pinsk M, Mammen C, Wade A, Scott SD, Canadian Childhood Nephrotic Syndrome Project T (2017) Factors influencing practice variation in the management of nephrotic syndrome: a qualitative study of pediatric nephrology care providers. CMAJ Open 5:E424–E430
    • (2017) CMAJ Open , vol.5 , pp. E424-E430
    • Samuel, S.M.1    Flynn, R.2    Zappitelli, M.3    Dart, A.4    Parekh, R.5    Pinsk, M.6    Mammen, C.7    Wade, A.8    Scott, S.D.9
  • 8
    • 84939641932 scopus 로고    scopus 로고
    • One hundred ways to kill a podocyte
    • COI: 1:CAS:528:DC%2BC2sXhs1WmsLzN, PID: 25637640
    • Saleem MA (2015) One hundred ways to kill a podocyte. Nephrol Dial Transplant 30:1266–1271
    • (2015) Nephrol Dial Transplant , vol.30 , pp. 1266-1271
    • Saleem, M.A.1
  • 11
    • 84860252806 scopus 로고    scopus 로고
    • Resolution of recurrent focal segmental glomerulosclerosis after retransplantation
    • COI: 1:CAS:528:DC%2BC38Xmt12ms7c%3D, PID: 22533598
    • Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366:1648–1649
    • (2012) N Engl J Med , vol.366 , pp. 1648-1649
    • Gallon, L.1    Leventhal, J.2    Skaro, A.3    Kanwar, Y.4    Alvarado, A.5
  • 12
    • 85013814227 scopus 로고    scopus 로고
    • Recent advances in understanding and treating nephrotic syndrome
    • PID: 28232870
    • Bierzynska A, Saleem M (2017) Recent advances in understanding and treating nephrotic syndrome. F1000Res 6:121
    • (2017) F1000Res , vol.6 , pp. 121
    • Bierzynska, A.1    Saleem, M.2
  • 13
    • 84959368700 scopus 로고    scopus 로고
    • A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues
    • COI: 1:CAS:528:DC%2BC1cXkvFGrtrs%3D, PID: 26613029
    • Wada T, Nangaku M (2015) A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues. Clin Kidney J 8:708–715
    • (2015) Clin Kidney J , vol.8 , pp. 708-715
    • Wada, T.1    Nangaku, M.2
  • 14
    • 84863988724 scopus 로고    scopus 로고
    • Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives
    • PID: 21710250
    • Elie V, Fakhoury M, Deschenes G, Jacqz-Aigrain E (2012) Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives. Pediatr Nephrol 27:1249–1256
    • (2012) Pediatr Nephrol , vol.27 , pp. 1249-1256
    • Elie, V.1    Fakhoury, M.2    Deschenes, G.3    Jacqz-Aigrain, E.4
  • 15
    • 0018188039 scopus 로고
    • Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis
    • Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159–165
    • (1978) A Report of the International Study of Kidney Disease in Children. Kidney Int , vol.13 , pp. 159-165
  • 16
    • 4544253691 scopus 로고    scopus 로고
    • Pharmacogenomics: bench to bedside
    • COI: 1:CAS:528:DC%2BD2cXntFCns7k%3D, PID: 15340384
    • Weinshilboum R, Wang L (2004) Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3:739–748
    • (2004) Nat Rev Drug Discov , vol.3 , pp. 739-748
    • Weinshilboum, R.1    Wang, L.2
  • 17
    • 0037421590 scopus 로고    scopus 로고
    • Pharmacogenomics—drug disposition, drug targets, and side effects
    • COI: 1:CAS:528:DC%2BD3sXovVKlsQ%3D%3D, PID: 12571262
    • Evans WE, McLeod HL (2003) Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 348:538–549
    • (2003) N Engl J Med , vol.348 , pp. 538-549
    • Evans, W.E.1    McLeod, H.L.2
  • 18
    • 0037421584 scopus 로고    scopus 로고
    • Inheritance and drug response
    • PID: 12571261
    • Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348:529–537
    • (2003) N Engl J Med , vol.348 , pp. 529-537
    • Weinshilboum, R.1
  • 20
    • 11844269814 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids
    • COI: 1:CAS:528:DC%2BD2MXhsVeisLc%3D, PID: 15634032
    • Czock D, Keller F, Rasche FM, Haussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44:61–98
    • (2005) Clin Pharmacokinet , vol.44 , pp. 61-98
    • Czock, D.1    Keller, F.2    Rasche, F.M.3    Haussler, U.4
  • 21
    • 0023018029 scopus 로고
    • Glucocorticoids: binding affinity and lipophilicity
    • COI: 1:CAS:528:DyaL2sXmtFenug%3D%3D, PID: 3795028
    • Ponec M, Kempenaar J, Shroot B, Caron JC (1986) Glucocorticoids: binding affinity and lipophilicity. J Pharm Sci 75:973–975
    • (1986) J Pharm Sci , vol.75 , pp. 973-975
    • Ponec, M.1    Kempenaar, J.2    Shroot, B.3    Caron, J.C.4
  • 22
    • 84903149823 scopus 로고    scopus 로고
    • Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles
    • COI: 1:CAS:528:DC%2BC2cXhtVCisrbE, PID: 24949977
    • Kirschke E, Goswami D, Southworth D, Griffin PR, Agard DA (2014) Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell 157:1685–1697
    • (2014) Cell , vol.157 , pp. 1685-1697
    • Kirschke, E.1    Goswami, D.2    Southworth, D.3    Griffin, P.R.4    Agard, D.A.5
  • 23
    • 0034915445 scopus 로고    scopus 로고
    • Molecular mechanisms of corticosteroid actions
    • COI: 1:STN:280:DC%2BD3s%2FisFCisw%3D%3D, PID: 12531061
    • Payne DN, Adcock IM (2001) Molecular mechanisms of corticosteroid actions. Paediatr Respir Rev 2:145–150
    • (2001) Paediatr Respir Rev , vol.2 , pp. 145-150
    • Payne, D.N.1    Adcock, I.M.2
  • 24
    • 77952951084 scopus 로고    scopus 로고
    • Mechanisms and resistance in glucocorticoid control of inflammation
    • COI: 1:CAS:528:DC%2BC3cXmsVGisr0%3D, PID: 20188830
    • Barnes PJ (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120:76–85
    • (2010) J Steroid Biochem Mol Biol , vol.120 , pp. 76-85
    • Barnes, P.J.1
  • 25
    • 0033773479 scopus 로고    scopus 로고
    • Molecular mechanisms of glucocorticosteroid actions
    • COI: 1:CAS:528:DC%2BD3cXkt1KntLo%3D, PID: 10873549
    • Adcock IM (2000) Molecular mechanisms of glucocorticosteroid actions. Pulm Pharmacol Ther 13:115–126
    • (2000) Pulm Pharmacol Ther , vol.13 , pp. 115-126
    • Adcock, I.M.1
  • 26
    • 0037329489 scopus 로고    scopus 로고
    • Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications
    • COI: 1:CAS:528:DC%2BD3sXptF2ntQ%3D%3D, PID: 12546654
    • Kagoshima M, Ito K, Cosio B, Adcock IM (2003) Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications. Biochem Soc Trans 31:60–65
    • (2003) Biochem Soc Trans , vol.31 , pp. 60-65
    • Kagoshima, M.1    Ito, K.2    Cosio, B.3    Adcock, I.M.4
  • 27
    • 44549088412 scopus 로고    scopus 로고
    • Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands
    • PID: 18221974
    • Lowenberg M, Stahn C, Hommes DW, Buttgereit F (2008) Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids 73:1025–1029
    • (2008) Steroids , vol.73 , pp. 1025-1029
    • Lowenberg, M.1    Stahn, C.2    Hommes, D.W.3    Buttgereit, F.4
  • 28
    • 77954859194 scopus 로고    scopus 로고
    • Genomic and non-genomic actions of glucocorticoids in asthma
    • PID: 20835306
    • Alangari AA (2010) Genomic and non-genomic actions of glucocorticoids in asthma. Ann Thorac Med 5:133–139
    • (2010) Ann Thorac Med , vol.5 , pp. 133-139
    • Alangari, A.A.1
  • 29
    • 0034059188 scopus 로고    scopus 로고
    • Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism
    • COI: 1:CAS:528:DC%2BD3cXjsl2mtbk%3D, PID: 10807665
    • Croxtall JD, Choudhury Q, Flower RJ (2000) Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130:289–298
    • (2000) Br J Pharmacol , vol.130 , pp. 289-298
    • Croxtall, J.D.1    Choudhury, Q.2    Flower, R.J.3
  • 30
    • 0025123626 scopus 로고
    • Pharmacokinetics of prednisolone in children with the nephrotic syndrome
    • COI: 1:STN:280:DyaK3M%2FlsV2nuw%3D%3D, PID: 2242307
    • Rostin M, Barthe P, Houin G, Alvinerie M, Bouissou F (1990) Pharmacokinetics of prednisolone in children with the nephrotic syndrome. Pediatr Nephrol 4:470–473
    • (1990) Pediatr Nephrol , vol.4 , pp. 470-473
    • Rostin, M.1    Barthe, P.2    Houin, G.3    Alvinerie, M.4    Bouissou, F.5
  • 31
    • 0021220158 scopus 로고
    • Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission
    • COI: 1:STN:280:DyaL2c3gtlejtg%3D%3D, PID: 6721988
    • Gatti G, Perucca E, Frigo GM, Notarangelo LD, Barberis L, Martini A (1984) Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission. Br J Clin Pharmacol 17:423–431
    • (1984) Br J Clin Pharmacol , vol.17 , pp. 423-431
    • Gatti, G.1    Perucca, E.2    Frigo, G.M.3    Notarangelo, L.D.4    Barberis, L.5    Martini, A.6
  • 32
    • 0019857278 scopus 로고
    • Dose dependent pharmacokinetics of prednisone and prednisolone in man
    • COI: 1:CAS:528:DyaL38XivV2htQ%3D%3D, PID: 7310640
    • Rose JQ, Yurchak AM, Jusko WJ (1981) Dose dependent pharmacokinetics of prednisone and prednisolone in man. J Pharmacokinet Biopharm 9:389–417
    • (1981) J Pharmacokinet Biopharm , vol.9 , pp. 389-417
    • Rose, J.Q.1    Yurchak, A.M.2    Jusko, W.J.3
  • 33
    • 0018000329 scopus 로고
    • Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity
    • COI: 1:CAS:528:DyaE1cXlsFOksLg%3D, PID: 671172
    • Green OC, Winter RJ, Kawahara FS, Phillips LS, Lewy PR, Hart RL, Pachman LM (1978) Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr 93:299–303
    • (1978) J Pediatr , vol.93 , pp. 299-303
    • Green, O.C.1    Winter, R.J.2    Kawahara, F.S.3    Phillips, L.S.4    Lewy, P.R.5    Hart, R.L.6    Pachman, L.M.7
  • 34
    • 0020182165 scopus 로고
    • Effect on nephrotic syndrome on absorption and disposition of prednisolone in children
    • PID: 7141787
    • Rocci ML Jr, Assael BM, Appiani AC, Edefonti A, Jusko WJ (1982) Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. Int J Pediatr Nephrol 3:159–166
    • (1982) Int J Pediatr Nephrol , vol.3 , pp. 159-166
    • Rocci, M.L.1    Assael, B.M.2    Appiani, A.C.3    Edefonti, A.4    Jusko, W.J.5
  • 35
    • 0025302890 scopus 로고
    • Clinical pharmacokinetics of prednisone and prednisolone
    • COI: 1:STN:280:DyaK3czjs1amtw%3D%3D, PID: 2199128
    • Frey BM, Frey FJ (1990) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 19:126–146
    • (1990) Clin Pharmacokinet , vol.19 , pp. 126-146
    • Frey, B.M.1    Frey, F.J.2
  • 36
    • 0018777782 scopus 로고
    • Clinical pharmacokinetics of prednisone and prednisolone
    • COI: 1:CAS:528:DyaE1MXktlejtLw%3D, PID: 378499
    • Pickup ME (1979) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 4:111–128
    • (1979) Clin Pharmacokinet , vol.4 , pp. 111-128
    • Pickup, M.E.1
  • 37
    • 0021242174 scopus 로고
    • Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome
    • COI: 1:STN:280:DyaL2c7ltVyiug%3D%3D, PID: 6702820
    • Frey FJ, Frey BM (1984) Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome. Am J Kidney Dis 3:339–348
    • (1984) Am J Kidney Dis , vol.3 , pp. 339-348
    • Frey, F.J.1    Frey, B.M.2
  • 38
    • 0019963865 scopus 로고
    • Altered prednisolone kinetics in patients with the nephrotic syndrome
    • COI: 1:STN:280:DyaL3s%2FovFWnsg%3D%3D, PID: 7177276
    • Frey FJ, Frey BM (1982) Altered prednisolone kinetics in patients with the nephrotic syndrome. Nephron 32:45–48
    • (1982) Nephron , vol.32 , pp. 45-48
    • Frey, F.J.1    Frey, B.M.2
  • 40
    • 0025157139 scopus 로고
    • Pharmacokinetics of prednisolone in children with nephrosis
    • COI: 1:STN:280:DyaK3c7pslamsw%3D%3D, PID: 2317067
    • Miller PF, Bowmer CJ, Wheeldon J, Brocklebank JT (1990) Pharmacokinetics of prednisolone in children with nephrosis. Arch Dis Child 65:196–200
    • (1990) Arch Dis Child , vol.65 , pp. 196-200
    • Miller, P.F.1    Bowmer, C.J.2    Wheeldon, J.3    Brocklebank, J.T.4
  • 42
    • 0020520379 scopus 로고
    • Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis
    • COI: 1:STN:280:DyaL3s3psFeruw%3D%3D, PID: 6887699
    • Bergrem H (1983) Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis. Kidney Int 23:876–881
    • (1983) Kidney Int , vol.23 , pp. 876-881
    • Bergrem, H.1
  • 43
    • 0016582785 scopus 로고
    • Pharmacokinetics of drugs in patients with the nephrotic syndrome
    • COI: 1:CAS:528:DyaE2MXktlOntLc%3D, PID: 1133166
    • Gugler R, Shoeman DW, Huffman DH, Cohlmia JB, Azarnoff DL (1975) Pharmacokinetics of drugs in patients with the nephrotic syndrome. J Clin Invest 55:1182–1189
    • (1975) J Clin Invest , vol.55 , pp. 1182-1189
    • Gugler, R.1    Shoeman, D.W.2    Huffman, D.H.3    Cohlmia, J.B.4    Azarnoff, D.L.5
  • 45
    • 0024498864 scopus 로고
    • Impact of ketoconazole on the metabolism of prednisolone
    • COI: 1:STN:280:DyaL1M7psFyntg%3D%3D, PID: 2639662
    • Zurcher RM, Frey BM, Frey FJ (1989) Impact of ketoconazole on the metabolism of prednisolone. Clin Pharmacol Ther 45:366–372
    • (1989) Clin Pharmacol Ther , vol.45 , pp. 366-372
    • Zurcher, R.M.1    Frey, B.M.2    Frey, F.J.3
  • 46
    • 0027422106 scopus 로고
    • Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin
    • COI: 1:CAS:528:DyaK2cXotlU%3D, PID: 8276057
    • Lee KH, Shin JG, Chong WS, Kim S, Lee JS, Jang IJ, Shin SG (1993) Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin. Eur J Clin Pharmacol 45:287–289
    • (1993) Eur J Clin Pharmacol , vol.45 , pp. 287-289
    • Lee, K.H.1    Shin, J.G.2    Chong, W.S.3    Kim, S.4    Lee, J.S.5    Jang, I.J.6    Shin, S.G.7
  • 47
    • 0023635107 scopus 로고
    • Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy
    • COI: 1:STN:280:DyaL1c%2FivVaksw%3D%3D, PID: 3665340
    • Bartoszek M, Brenner AM, Szefler SJ (1987) Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin Pharmacol Ther 42:424–432
    • (1987) Clin Pharmacol Ther , vol.42 , pp. 424-432
    • Bartoszek, M.1    Brenner, A.M.2    Szefler, S.J.3
  • 48
    • 84873464631 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation
    • COI: 1:CAS:528:DC%2BC3sXisFek, PID: 23018468
    • Bergmann TK, Barraclough KA, Lee KJ, Staatz CE (2012) Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation. Clin Pharmacokinet 51:711–741
    • (2012) Clin Pharmacokinet , vol.51 , pp. 711-741
    • Bergmann, T.K.1    Barraclough, K.A.2    Lee, K.J.3    Staatz, C.E.4
  • 49
    • 0023227287 scopus 로고
    • Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation
    • COI: 1:STN:280:DyaL2s3gslSqug%3D%3D, PID: 3554641
    • Frey FJ, Schnetzer A, Horber FF, Frey BM (1987) Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation. Transplantation 43:494–498
    • (1987) Transplantation , vol.43 , pp. 494-498
    • Frey, F.J.1    Schnetzer, A.2    Horber, F.F.3    Frey, B.M.4
  • 50
    • 0030804652 scopus 로고    scopus 로고
    • Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome
    • COI: 1:STN:280:DyaK2svmsVGksA%3D%3D, PID: 9323286
    • Ekka BK, Bagga A, Srivastava RN (1997) Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 11:597–599
    • (1997) Pediatr Nephrol , vol.11 , pp. 597-599
    • Ekka, B.K.1    Bagga, A.2    Srivastava, R.N.3
  • 51
    • 0142067563 scopus 로고    scopus 로고
    • Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor
    • COI: 1:CAS:528:DC%2BD3sXltVaqu7o%3D, PID: 12673034
    • Usui T, Saitoh Y, Komada F (2003) Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull 26:510–517
    • (2003) Biol Pharm Bull , vol.26 , pp. 510-517
    • Usui, T.1    Saitoh, Y.2    Komada, F.3
  • 52
    • 0036851317 scopus 로고    scopus 로고
    • Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy
    • COI: 1:CAS:528:DC%2BD38XptVSiurk%3D, PID: 12451243
    • Shimada T, Terada A, Yokogawa K, Kaneko H, Nomura M, Kaji K, Kaneko S, Kobayashi K, Miyamoto K (2002) Lowered blood concentration of tacrolimus and its recovery with changes in expression of CYP3A and P-glycoprotein after high-dose steroid therapy. Transplantation 74:1419–1424
    • (2002) Transplantation , vol.74 , pp. 1419-1424
    • Shimada, T.1    Terada, A.2    Yokogawa, K.3    Kaneko, H.4    Nomura, M.5    Kaji, K.6    Kaneko, S.7    Kobayashi, K.8    Miyamoto, K.9
  • 53
    • 84882696152 scopus 로고    scopus 로고
    • P-glycoprotein inhibition for optimal drug delivery
    • PID: 24023511
    • Amin ML (2013) P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7:27–34
    • (2013) Drug Target Insights , vol.7 , pp. 27-34
    • Amin, M.L.1
  • 54
    • 0030026713 scopus 로고    scopus 로고
    • Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
    • COI: 1:CAS:528:DyaK28Xktlalsbc%3D, PID: 8771358
    • Bamberger CM, Schulte HM, Chrousos GP (1996) Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 17:245–261
    • (1996) Endocr Rev , vol.17 , pp. 245-261
    • Bamberger, C.M.1    Schulte, H.M.2    Chrousos, G.P.3
  • 56
    • 34547863538 scopus 로고    scopus 로고
    • Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists
    • COI: 1:CAS:528:DC%2BD2sXpt1Sktbk%3D, PID: 17630118
    • Stahn C, Lowenberg M, Hommes DW, Buttgereit F (2007) Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275:71–78
    • (2007) Mol Cell Endocrinol , vol.275 , pp. 71-78
    • Stahn, C.1    Lowenberg, M.2    Hommes, D.W.3    Buttgereit, F.4
  • 57
    • 0042466540 scopus 로고    scopus 로고
    • Nephrotic syndrome in childhood
    • PID: 12944064
    • Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639
    • (2003) Lancet , vol.362 , pp. 629-639
    • Eddy, A.A.1    Symons, J.M.2
  • 60
    • 32844469380 scopus 로고    scopus 로고
    • Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization
    • COI: 1:CAS:528:DC%2BD28XhslSmuw%3D%3D, PID: 16316324
    • Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE (2005) Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 68:2473–2483
    • (2005) Kidney Int , vol.68 , pp. 2473-2483
    • Ransom, R.F.1    Lam, N.G.2    Hallett, M.A.3    Atkinson, S.J.4    Smoyer, W.E.5
  • 61
    • 33644801094 scopus 로고    scopus 로고
    • Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins
    • COI: 1:CAS:528:DC%2BD2MXhtFeisL3F, PID: 15987750
    • Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ (2005) Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16:2615–2625
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2615-2625
    • Wada, T.1    Pippin, J.W.2    Marshall, C.B.3    Griffin, S.V.4    Shankland, S.J.5
  • 63
    • 84989899656 scopus 로고    scopus 로고
    • Glomerular glucocorticoid receptors expression and clinicopathological types of childhood nephrotic syndrome
    • COI: 1:CAS:528:DC%2BC28Xhs1Ggu73E, PID: 27690709
    • Gamal Y, Badawy A, Swelam S, Tawfeek MS, Gad EF (2017) Glomerular glucocorticoid receptors expression and clinicopathological types of childhood nephrotic syndrome. Fetal Pediatr Pathol 36:16–26
    • (2017) Fetal Pediatr Pathol , vol.36 , pp. 16-26
    • Gamal, Y.1    Badawy, A.2    Swelam, S.3    Tawfeek, M.S.4    Gad, E.F.5
  • 64
    • 0037407508 scopus 로고    scopus 로고
    • Pharmacogenomics: marshalling the human genome to individualise drug therapy
    • COI: 1:CAS:528:DC%2BD3sXktVSksrg%3D, PID: 12651877
    • Evans WE (2003) Pharmacogenomics: marshalling the human genome to individualise drug therapy. Gut 52(Suppl 2):ii10–ii18
    • (2003) Gut , vol.52 , pp. ii10-ii18
    • Evans, W.E.1
  • 65
    • 85036568358 scopus 로고    scopus 로고
    • Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients
    • COI: 1:CAS:528:DC%2BC2sXhslCmt7bK, PID: 29084469
    • Andrews LM, Li Y, De Winter BCM, Shi YY, Baan CC, Van Gelder T, Hesselink DA (2017) Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Expert Opin Drug Metab Toxicol 13:1225–1236
    • (2017) Expert Opin Drug Metab Toxicol , vol.13 , pp. 1225-1236
    • Andrews, L.M.1    Li, Y.2    De Winter, B.C.M.3    Shi, Y.Y.4    Baan, C.C.5    Van Gelder, T.6    Hesselink, D.A.7
  • 66
    • 84877645710 scopus 로고    scopus 로고
    • Pharmacogenetics in clinical practice: how far have we come and where are we going?
    • COI: 1:CAS:528:DC%2BC3sXntF2jt70%3D, PID: 23651030
    • Johnson JA (2013) Pharmacogenetics in clinical practice: how far have we come and where are we going? Pharmacogenomics 14:835–843
    • (2013) Pharmacogenomics , vol.14 , pp. 835-843
    • Johnson, J.A.1
  • 70
    • 44449161294 scopus 로고    scopus 로고
    • Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome
    • PID: 18343955
    • Zalewski G, Wasilewska A, Zoch-Zwierz W, Chyczewski L (2008) Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol 23:1073–1078
    • (2008) Pediatr Nephrol , vol.23 , pp. 1073-1078
    • Zalewski, G.1    Wasilewska, A.2    Zoch-Zwierz, W.3    Chyczewski, L.4
  • 71
    • 84973312197 scopus 로고    scopus 로고
    • Single nucleotide polymorphisms in pediatric idiopathic nephrotic syndrome
    • PID: 27247801
    • Suvanto M, Jahnukainen T, Kestila M, Jalanko H (2016) Single nucleotide polymorphisms in pediatric idiopathic nephrotic syndrome. Int J Nephrol 2016:1417456
    • (2016) Int J Nephrol , vol.2016 , pp. 1417456
    • Suvanto, M.1    Jahnukainen, T.2    Kestila, M.3    Jalanko, H.4
  • 72
    • 85038589340 scopus 로고    scopus 로고
    • NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome
    • Liu J, Wan Z, Song Q, Li Z, He Y, Tang Y, Xie W, Xie Y, Zhang J (2017) NR3C1 gene polymorphisms are associated with steroid resistance in patients with primary nephrotic syndrome. Pharmacogenomics. 10.2217/pgs-2017-0084
    • (2017) Pharmacogenomics
    • Liu, J.1    Wan, Z.2    Song, Q.3    Li, Z.4    He, Y.5    Tang, Y.6    Xie, W.7    Xie, Y.8    Zhang, J.9
  • 73
    • 85034217208 scopus 로고    scopus 로고
    • Association of single-nucleotide polymorphism in the FKBP5 gene with response to steroids in pediatric patients with primary nephrotic syndrome
    • COI: 1:CAS:528:DC%2BC1cXitFOht7vE, PID: 28992850
    • Du N, Yang F, Li L, Liu X, Sun L, Zhang S, He X, Tang Y, Shi J, Liu C, Zhang X (2017) Association of single-nucleotide polymorphism in the FKBP5 gene with response to steroids in pediatric patients with primary nephrotic syndrome. Clin Nephrol 88:338–343
    • (2017) Clin Nephrol , vol.88 , pp. 338-343
    • Du, N.1    Yang, F.2    Li, L.3    Liu, X.4    Sun, L.5    Zhang, S.6    He, X.7    Tang, Y.8    Shi, J.9    Liu, C.10    Zhang, X.11
  • 74
    • 0042628036 scopus 로고    scopus 로고
    • Polymorphisms of interleukin-4-related genes in Japanese children with minimal change nephrotic syndrome
    • COI: 1:CAS:528:DC%2BD3sXmvFymsLs%3D, PID: 12900808
    • Kobayashi Y, Arakawa H, Suzuki M, Takizawa T, Tokuyama K, Morikawa A (2003) Polymorphisms of interleukin-4-related genes in Japanese children with minimal change nephrotic syndrome. Am J Kidney Dis 42:271–276
    • (2003) Am J Kidney Dis , vol.42 , pp. 271-276
    • Kobayashi, Y.1    Arakawa, H.2    Suzuki, M.3    Takizawa, T.4    Tokuyama, K.5    Morikawa, A.6
  • 77
    • 59849117618 scopus 로고    scopus 로고
    • Polymorphisms in interleukin-4-related genes in patients with minimal change nephrotic syndrome
    • PID: 19011907
    • Ikeuchi Y, Kobayashi Y, Arakawa H, Suzuki M, Tamra K, Morikawa A (2009) Polymorphisms in interleukin-4-related genes in patients with minimal change nephrotic syndrome. Pediatr Nephrol 24:489–495
    • (2009) Pediatr Nephrol , vol.24 , pp. 489-495
    • Ikeuchi, Y.1    Kobayashi, Y.2    Arakawa, H.3    Suzuki, M.4    Tamra, K.5    Morikawa, A.6
  • 79
    • 27644515237 scopus 로고    scopus 로고
    • Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome
    • PID: 16133063
    • Berdeli A, Mir S, Ozkayin N, Serdaroglu E, Tabel Y, Cura A (2005) Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome. Pediatr Nephrol 20:1566–1571
    • (2005) Pediatr Nephrol , vol.20 , pp. 1566-1571
    • Berdeli, A.1    Mir, S.2    Ozkayin, N.3    Serdaroglu, E.4    Tabel, Y.5    Cura, A.6
  • 81
    • 84946781653 scopus 로고    scopus 로고
    • A genetic study of steroid-resistant nephrotic syndrome: relationship between polymorphism -173 G to C in the MIF gene and serum level MIF in children
    • COI: 1:CAS:528:DC%2BC2MXitVymtb%2FL, PID: 26541175
    • Ramayani OR, Sekarwana N, Trihono PP, Sadewa AH, Lelo A (2016) A genetic study of steroid-resistant nephrotic syndrome: relationship between polymorphism -173 G to C in the MIF gene and serum level MIF in children. J Dev Orig Health Dis 7:102–107
    • (2016) J Dev Orig Health Dis , vol.7 , pp. 102-107
    • Ramayani, O.R.1    Sekarwana, N.2    Trihono, P.P.3    Sadewa, A.H.4    Lelo, A.5
  • 82
    • 33846441202 scopus 로고    scopus 로고
    • MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children
    • PID: 17043887
    • Wasilewska A, Zalewski G, Chyczewski L, Zoch-Zwierz W (2007) MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol 22:44–51
    • (2007) Pediatr Nephrol , vol.22 , pp. 44-51
    • Wasilewska, A.1    Zalewski, G.2    Chyczewski, L.3    Zoch-Zwierz, W.4
  • 83
    • 84864466340 scopus 로고    scopus 로고
    • Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome
    • PID: 22610055
    • Chiou YH, Wang LY, Wang TH, Huang SP (2012) Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome. Pediatr Nephrol 27:1511–1517
    • (2012) Pediatr Nephrol , vol.27 , pp. 1511-1517
    • Chiou, Y.H.1    Wang, L.Y.2    Wang, T.H.3    Huang, S.P.4
  • 84
    • 84884531850 scopus 로고    scopus 로고
    • Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids
    • COI: 1:CAS:528:DC%2BC3sXhsVeis7vE, PID: 23994685
    • Youssef DM, Attia TA, El-Shal AS, Abduelometty FA (2013) Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids. Gene 530:201–207
    • (2013) Gene , vol.530 , pp. 201-207
    • Youssef, D.M.1    Attia, T.A.2    El-Shal, A.S.3    Abduelometty, F.A.4
  • 85
    • 82255164317 scopus 로고    scopus 로고
    • MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children
    • COI: 1:CAS:528:DC%2BC3MXhsFGjt7vO, PID: 21460357
    • Jafar T, Prasad N, Agarwal V, Mahdi A, Gupta A, Sharma RK, Negi MP, Agrawal S (2011) MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant 26:3968–3974
    • (2011) Nephrol Dial Transplant , vol.26 , pp. 3968-3974
    • Jafar, T.1    Prasad, N.2    Agarwal, V.3    Mahdi, A.4    Gupta, A.5    Sharma, R.K.6    Negi, M.P.7    Agrawal, S.8
  • 86
    • 84990932235 scopus 로고    scopus 로고
    • ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome
    • PID: 27719329
    • Safan MA, Elhelbawy NG, Midan DA, Khader HF (2017) ABCB1 polymorphisms and steroid treatment in children with idiopathic nephrotic syndrome. Br J Biomed Sci 74:36–41
    • (2017) Br J Biomed Sci , vol.74 , pp. 36-41
    • Safan, M.A.1    Elhelbawy, N.G.2    Midan, D.A.3    Khader, H.F.4
  • 88
    • 2342425073 scopus 로고    scopus 로고
    • Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition
    • PID: 14749509
    • van Rossum EF, Lamberts SW (2004) Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 59:333–357
    • (2004) Recent Prog Horm Res , vol.59 , pp. 333-357
    • van Rossum, E.F.1    Lamberts, S.W.2
  • 90
    • 84962360834 scopus 로고    scopus 로고
    • Some GCR polymorphisms (N363S, ER22/23EK, and Bcl-1) may influence steroid-induced toxicities and survival rates in children with ALL
    • COI: 1:CAS:528:DC%2BC28XhtVKju7bF, PID: 27050122
    • Eipel O, Hegyi M, Csordas K, Nemeth K, Luczay A, Torok D, Csoka M, Erdelyi D, Kovacs G (2016) Some GCR polymorphisms (N363S, ER22/23EK, and Bcl-1) may influence steroid-induced toxicities and survival rates in children with ALL. J Pediatr Hematol Oncol 38:334–340
    • (2016) J Pediatr Hematol Oncol , vol.38 , pp. 334-340
    • Eipel, O.1    Hegyi, M.2    Csordas, K.3    Nemeth, K.4    Luczay, A.5    Torok, D.6    Csoka, M.7    Erdelyi, D.8    Kovacs, G.9
  • 91
    • 84887587736 scopus 로고    scopus 로고
    • The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy
    • COI: 1:CAS:528:DC%2BC3sXjtFGit7g%3D, PID: 23355259
    • Eipel OT, Nemeth K, Torok D, Csordas K, Hegyi M, Ponyi A, Ferenczy A, Erdelyi DJ, Csoka M, Kovacs GT (2013) The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy. Int J Hematol 97:216–222
    • (2013) Int J Hematol , vol.97 , pp. 216-222
    • Eipel, O.T.1    Nemeth, K.2    Torok, D.3    Csordas, K.4    Hegyi, M.5    Ponyi, A.6    Ferenczy, A.7    Erdelyi, D.J.8    Csoka, M.9    Kovacs, G.T.10
  • 94
    • 84866105906 scopus 로고    scopus 로고
    • Nuclear HSP90 regulates the glucocorticoid responsiveness of PBMCs in patients with idiopathic nephrotic syndrome
    • COI: 1:CAS:528:DC%2BC38XhsValsb7M, PID: 22926076
    • Ouyang J, Chen P, Jiang T, Chen Y, Li J (2012) Nuclear HSP90 regulates the glucocorticoid responsiveness of PBMCs in patients with idiopathic nephrotic syndrome. Int Immunopharmacol 14:334–340
    • (2012) Int Immunopharmacol , vol.14 , pp. 334-340
    • Ouyang, J.1    Chen, P.2    Jiang, T.3    Chen, Y.4    Li, J.5
  • 95
    • 0034787697 scopus 로고    scopus 로고
    • Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics
    • COI: 1:CAS:528:DC%2BD3MXot1CnsLo%3D, PID: 11677765
    • Qian X, Zhu Y, Xu W, Lin Y (2001) Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics. Chin Med J 114:1051–1054
    • (2001) Chin Med J , vol.114 , pp. 1051-1054
    • Qian, X.1    Zhu, Y.2    Xu, W.3    Lin, Y.4
  • 97
    • 84866738606 scopus 로고    scopus 로고
    • Glucocorticoid resistance in Crohn’s disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms
    • COI: 1:CAS:528:DC%2BC3MXptlakt74%3D, PID: 21788965
    • Maltese P, Palma L, Sfara C, de Rocco P, Latiano A, Palmieri O, Corritore G, Annese V, Magnani M (2012) Glucocorticoid resistance in Crohn’s disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms. Pharmacogenomics J 12:432–438
    • (2012) Pharmacogenomics J , vol.12 , pp. 432-438
    • Maltese, P.1    Palma, L.2    Sfara, C.3    de Rocco, P.4    Latiano, A.5    Palmieri, O.6    Corritore, G.7    Annese, V.8    Magnani, M.9
  • 98
    • 70249091813 scopus 로고    scopus 로고
    • Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma
    • PID: 19619331
    • Raby BA, Van Steen K, Lasky-Su J, Tantisira K, Kaplan F, Weiss ST (2009) Importin-13 genetic variation is associated with improved airway responsiveness in childhood asthma. Respir Res 10:67
    • (2009) Respir Res , vol.10 , pp. 67
    • Raby, B.A.1    Van Steen, K.2    Lasky-Su, J.3    Tantisira, K.4    Kaplan, F.5    Weiss, S.T.6
  • 99
    • 0015857208 scopus 로고
    • Serum IgE in patients with minimal-change nephrotic syndrome
    • COI: 1:STN:280:DyaE2c%2FgsFWhsw%3D%3D, PID: 4742569
    • Groshong T, Mendelson L, Mendoza S, Bazaral M, Hamburger R, Tune B (1973) Serum IgE in patients with minimal-change nephrotic syndrome. J Pediatr 83:767–771
    • (1973) J Pediatr , vol.83 , pp. 767-771
    • Groshong, T.1    Mendelson, L.2    Mendoza, S.3    Bazaral, M.4    Hamburger, R.5    Tune, B.6
  • 100
    • 0001325237 scopus 로고    scopus 로고
    • The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
    • COI: 1:STN:280:DyaK1c%2FktFyjsQ%3D%3D, PID: 9392697
    • Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337:1720–1725
    • (1997) N Engl J Med , vol.337 , pp. 1720-1725
    • Hershey, G.K.1    Friedrich, M.F.2    Esswein, L.A.3    Thomas, M.L.4    Chatila, T.A.5
  • 102
    • 0032988804 scopus 로고    scopus 로고
    • Interleukin-4 and interleukin-4 receptor polymorphisms in minimal change nephropathy
    • COI: 1:CAS:528:DyaK1MXktFyqtbg%3D
    • Parry RG, Gillespie KM, Parnham A, Clark AG, Mathieson PW (1999) Interleukin-4 and interleukin-4 receptor polymorphisms in minimal change nephropathy. Clin Sci (Lond) 96:665–668
    • (1999) Clin Sci (Lond) , vol.96 , pp. 665-668
    • Parry, R.G.1    Gillespie, K.M.2    Parnham, A.3    Clark, A.G.4    Mathieson, P.W.5
  • 103
    • 17144409438 scopus 로고    scopus 로고
    • Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease
    • COI: 1:CAS:528:DC%2BD2MXisVGqtrY%3D, PID: 15728267
    • Wei CL, Cheung W, Heng CK, Arty N, Chong SS, Lee BW, Puah KL, Yap HK (2005) Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease. Nephrol Dial Transplant 20:728–734
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 728-734
    • Wei, C.L.1    Cheung, W.2    Heng, C.K.3    Arty, N.4    Chong, S.S.5    Lee, B.W.6    Puah, K.L.7    Yap, H.K.8
  • 105
    • 84897946664 scopus 로고    scopus 로고
    • Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome
    • PID: 24644543
    • Swierczewska M, Ostalska-Nowicka D, Kempisty B, Szczepankiewicz A, Nowicki M (2014) Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome. Acta Biochim Pol 61:67–75
    • (2014) Acta Biochim Pol , vol.61 , pp. 67-75
    • Swierczewska, M.1    Ostalska-Nowicka, D.2    Kempisty, B.3    Szczepankiewicz, A.4    Nowicki, M.5
  • 106
    • 84921517912 scopus 로고    scopus 로고
    • Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis
    • COI: 1:CAS:528:DC%2BC2MXhsl2is7s%3D
    • Tong X, He J, Liu S, Peng S, Yan Z, Zhang Y, Fan H (2015) Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis. Nephrology (Carlton) 20:68–76
    • (2015) Nephrology (Carlton) , vol.20 , pp. 68-76
    • Tong, X.1    He, J.2    Liu, S.3    Peng, S.4    Yan, Z.5    Zhang, Y.6    Fan, H.7
  • 108
    • 0027538007 scopus 로고
    • Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans
    • COI: 1:STN:280:DyaK3s7ptV2mug%3D%3D, PID: 8447300
    • Suranyi MG, Guasch A, Hall BM, Myers BD (1993) Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 21:251–259
    • (1993) Am J Kidney Dis , vol.21 , pp. 251-259
    • Suranyi, M.G.1    Guasch, A.2    Hall, B.M.3    Myers, B.D.4
  • 109
    • 0027984488 scopus 로고
    • Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome
    • COI: 1:STN:280:DyaK2M3itVertQ%3D%3D
    • Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J (1994) Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Investig 24:799–805
    • (1994) Eur J Clin Investig , vol.24 , pp. 799-805
    • Bustos, C.1    Gonzalez, E.2    Muley, R.3    Alonso, J.L.4    Egido, J.5
  • 111
    • 85055900471 scopus 로고    scopus 로고
    • Preliminary study regarding the association between tumor necrosis factor alpha gene polymorphisms and childhood idiopathic nephrotic syndrome in Romanian pediatric patients
    • Tieranu I, Dutescu MI, Bara C, Tieranu CG, Balgradean M, Popa OM (2017) Preliminary study regarding the association between tumor necrosis factor alpha gene polymorphisms and childhood idiopathic nephrotic syndrome in Romanian pediatric patients. Maedica (Buchar) 12:164–168
    • (2017) Maedica (Buchar) , vol.12 , pp. 164-168
    • Tieranu, I.1    Dutescu, M.I.2    Bara, C.3    Tieranu, C.G.4    Balgradean, M.5    Popa, O.M.6
  • 112
    • 0028898022 scopus 로고
    • Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display
    • COI: 1:CAS:528:DyaK2MXktVSksb4%3D, PID: 7758820
    • Chapman MS, Qu N, Pascoe S, Chen WX, Apostol C, Gordon D, Miesfeld RL (1995) Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol Cell Endocrinol 108:R1–R7
    • (1995) Mol Cell Endocrinol , vol.108 , pp. R1-R7
    • Chapman, M.S.1    Qu, N.2    Pascoe, S.3    Chen, W.X.4    Apostol, C.5    Gordon, D.6    Miesfeld, R.L.7
  • 114
    • 84864477471 scopus 로고    scopus 로고
    • GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome
    • PID: 22660954
    • Cheong HI, Kang HG, Schlondorff J (2012) GLCCI1 single nucleotide polymorphisms in pediatric nephrotic syndrome. Pediatr Nephrol 27:1595–1599
    • (2012) Pediatr Nephrol , vol.27 , pp. 1595-1599
    • Cheong, H.I.1    Kang, H.G.2    Schlondorff, J.3
  • 115
  • 116
    • 33746963885 scopus 로고    scopus 로고
    • Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response
    • PID: 16761159
    • Wasilewska A, Zoch-Zwierz W, Pietruczuk M, Zalewski G (2006) Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol 21:1274–1280
    • (2006) Pediatr Nephrol , vol.21 , pp. 1274-1280
    • Wasilewska, A.1    Zoch-Zwierz, W.2    Pietruczuk, M.3    Zalewski, G.4
  • 118
    • 0038106665 scopus 로고    scopus 로고
    • Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
    • COI: 1:CAS:528:DC%2BD3sXkvFegtLY%3D, PID: 12831320
    • Sakaeda T, Nakamura T, Okumura K (2003) Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 4:397–410
    • (2003) Pharmacogenomics , vol.4 , pp. 397-410
    • Sakaeda, T.1    Nakamura, T.2    Okumura, K.3
  • 119
    • 85039699372 scopus 로고    scopus 로고
    • Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients
    • Conyers R, Devaraja S, Elliott D (2017) Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients. Pediatr Blood Cancer. 10.1002/pbc.26937
    • (2017) Pediatr Blood Cancer
    • Conyers, R.1    Devaraja, S.2    Elliott, D.3
  • 120
    • 84938374248 scopus 로고    scopus 로고
    • Association of ACE and MDR1 gene polymorphisms with steroid resistance in children with idiopathic nephrotic syndrome
    • COI: 1:CAS:528:DC%2BC2MXht12nurnJ, PID: 26154535
    • Dhandapani MC, Venkatesan V, Rengaswamy NB, Gowrishankar K, Nageswaran P, Perumal V (2015) Association of ACE and MDR1 gene polymorphisms with steroid resistance in children with idiopathic nephrotic syndrome. Genet Test Mol Biomarkers 19:454–456
    • (2015) Genet Test Mol Biomarkers , vol.19 , pp. 454-456
    • Dhandapani, M.C.1    Venkatesan, V.2    Rengaswamy, N.B.3    Gowrishankar, K.4    Nageswaran, P.5    Perumal, V.6
  • 121
    • 84920499880 scopus 로고    scopus 로고
    • MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results
    • COI: 1:CAS:528:DC%2BC1cXotl2ktLs%3D, PID: 25559283
    • Cizmarikova M, Podracka L, Klimcakova L, Habalova V, Boor A, Mojzis J, Mirossay L (2015) MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results. Med Sci Monit 21:59–68
    • (2015) Med Sci Monit , vol.21 , pp. 59-68
    • Cizmarikova, M.1    Podracka, L.2    Klimcakova, L.3    Habalova, V.4    Boor, A.5    Mojzis, J.6    Mirossay, L.7
  • 122
    • 85021859541 scopus 로고    scopus 로고
    • A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: susceptibility and steroid responsiveness
    • COI: 1:CAS:528:DC%2BC2sXpvVGqtrc%3D
    • Han SS, Xu YQ, Lu Y, Gu XC, Wang Y (2017) A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: susceptibility and steroid responsiveness. Medicine (Baltimore) 96:e7191
    • (2017) Medicine (Baltimore) , vol.96
    • Han, S.S.1    Xu, Y.Q.2    Lu, Y.3    Gu, X.C.4    Wang, Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.